Autolus Therapeutics plc is a United Kingdom-based early commercial-stage biopharmaceutical company developing programmed T cell therapies for the treatment of cancer and autoimmune diseases. The Company has an approved commercial product, AUCATZYL, for the treatment of adult patients with r/r B-ALL. Using a suite of proprietary and modular T cell programming technologies, it is also developing five programs in seven hematological and solid tumor indications and one autoimmune indication. It is engineering precisely targeted, controlled and highly active T cell therapies that are designed to better recognize target cells, break down their defense mechanisms and attack and eliminate these cells. Its product pipeline includes obe-cel (ALLCAR19), obe-cel (CAROUSEL), AUTO1/22 (CARPALL), AUTO4 (LibrA T1), AUTO6 (MAGNETO), AUTO5, AUTO8 (MCARTY) and AUTO9. AUTO4 and AUTO5 are two programmed T cell therapies for the treatment of peripheral T-cell lymphoma targeting TRBC 1 and TRBC 2.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļAUTL
āļāļ·āđāļāļāļĢāļīāļĐāļąāļAutolus Therapeutics PLC
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļJun 22, 2018
āļāļĩāļāļĩāđāļItin (Christian Martin)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ647
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒDepository Receipt
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļJun 22
āļāļĩāđāļāļĒāļđāđThe Mediaworks
āđāļĄāļ·āļāļLONDON
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX - NASDAQ BASIC
āļāļĢāļ°āđāļāļĻUnited Kingdom
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđW12 7FP
āđāļāļĢāļĻāļąāļāļāđ442038296230
āđāļ§āđāļāđāļāļāđhttps://www.autolus.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļAUTL
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļJun 22, 2018
āļāļĩāļāļĩāđāļItin (Christian Martin)
Ms. Cynthia M. Butitta
Non-Executive Independent Director
Non-Executive Independent Director
Mr. Brent Rice
Senior Vice President, Chief Commercial Officer
Senior Vice President, Chief Commercial Officer
Mr. Robert W. (Bob) Azelby
Mr. Robert W. (Bob) Azelby
Non-Executive Independent Director
Non-Executive Independent Director
Mr. Ryan Richardson
Director
Mr. Christopher Williams
Senior Vice President, Chief Business Development Officer
Senior Vice President, Chief Business Development Officer
Mr. Alexander Swan
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
Ms. Miranda Neville
Senior Vice President, Chief Project Officer
Senior Vice President, Chief Project Officer
Mr. Alex Driggs
Senior Vice President, Legal Affairs and General Counsel
Senior Vice President, Legal Affairs and General Counsel
Dr. Robert Iannone, M.D.
Non-Executive Independent Director
Non-Executive Independent Director
Mr. Robert (Rob) Dolski
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Ms. Cynthia M. Butitta
Non-Executive Independent Director
Non-Executive Independent Director
Mr. Brent Rice
Senior Vice President, Chief Commercial Officer
Senior Vice President, Chief Commercial Officer
Mr. Robert W. (Bob) Azelby
Mr. Robert W. (Bob) Azelby
Non-Executive Independent Director
Non-Executive Independent Director
Mr. Ryan Richardson
Director
Mr. Christopher Williams
Senior Vice President, Chief Business Development Officer
Senior Vice President, Chief Business Development Officer
Mr. Alexander Swan
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President